Insights Stine Krag Brunvold 8/15/23 Insights Stine Krag Brunvold 8/15/23 Spinal Muscular Atrophy (SMA) Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Claus Read More Insights Stine Krag Brunvold 8/8/22 Insights Stine Krag Brunvold 8/8/22 Spinal Muscular Atrophy (SMA) Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Eden Read More Insights Stine Krag Brunvold 6/21/22 Insights Stine Krag Brunvold 6/21/22 Myasthenia Gravis Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Ulrik Read More Insights Stine Krag Brunvold 6/16/22 Insights Stine Krag Brunvold 6/16/22 Myasthenia Gravis Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Sofie Read More Insights Stine Krag Brunvold 6/25/21 Insights Stine Krag Brunvold 6/25/21 Interview with Professor, Dr. Geert Jan Groeneveld about myasthenia gravis Read More
Insights Stine Krag Brunvold 8/15/23 Insights Stine Krag Brunvold 8/15/23 Spinal Muscular Atrophy (SMA) Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Claus Read More
Insights Stine Krag Brunvold 8/8/22 Insights Stine Krag Brunvold 8/8/22 Spinal Muscular Atrophy (SMA) Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Eden Read More
Insights Stine Krag Brunvold 6/21/22 Insights Stine Krag Brunvold 6/21/22 Myasthenia Gravis Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Ulrik Read More
Insights Stine Krag Brunvold 6/16/22 Insights Stine Krag Brunvold 6/16/22 Myasthenia Gravis Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Sofie Read More
Insights Stine Krag Brunvold 6/25/21 Insights Stine Krag Brunvold 6/25/21 Interview with Professor, Dr. Geert Jan Groeneveld about myasthenia gravis Read More
